Kevin D. Bunker, Chief Operating Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 19,166 shares at $71.17 ($1.4M) on 2021-12-10, disclosed to the SEC on 2021-12-13.
Open-market sale of $1.4M ZNTL by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.29 | 434 | $31K | 2.2% |
| 2 | $71.17 | 4,049 | $288K | 21.0% |
| 3 | $71.17 | 4,049 | $288K | 21.0% |
| 4 | $72.10 | 5,117 | $369K | 26.8% |
| 5 | $72.10 | 5,117 | $369K | 26.8% |
| 6 | $73.75 | 400 |
| $30K |
| 2.1% |
| Total | $71.70 avg | 19,166 | $1.4M | 100% |
| Filing → |
| ZNTL | SELL | 2023-02-14 | $285K | — | Filing → |
| ZNTL | SELL | 2022-08-12 | $150K | — | Filing → |
| ZNTL | SELL | 2022-07-20 | $150K | — | Filing → |